Brosur untuk Korea market

Introduction

  • PT EMJ was established on 2012 in Surabaya, Indonesia with the main objectives are to provide fish resources in excellent quality for export market by following the controlled processes. Through our experiences and networking capabilities, we have provided various freshwater and seawater fish such as skipjack, tuna, milkfish, squids, octopus, etc. Since the establishment year, we have grown rapidly and has built several processing plants.
  • The head quarter of the company is located at Surabaya, while the processing plant is at Sidoarjo, Indonesia. We have determined to strive serving, achieveng, and delivering customer satisfaction throughout our dedicated and well trained personel.
  • Customer satisfactions have always been our first priority and these promises confidently has been delivered.

Vision

Become a trusted partner for fish supplies with the highest standard in safety, quality, and sustainability.

Mission

Achieve customer satisfaction through process optimization, product expertise, and system efficiency.


  1. Frozen fish
    1. Skipjack tuna
    2. Yellowfin tuna
    3. Longtail tuna
    4. Bonito tuna
    5. Lamadang
    6. Layur
    7. Tengiri/ Spanish Mackerel
    8. Gulama
    9. Milkfish
    10. Frigattte Mackerel
    11. Indian Mackerel
    12. Muroaji
    13. Flying Fish
    14. Headlesh Fying Fish 
    15. Sardines
    16. Flower Octopus
    17. Ball type Octopus
    18. Octopus in Block
    19. Baby Octopus
    20. Cuttle Fish
    21. Squid
    22. Cut tuna in vacuum pack


Popular posts from this blog

Frost on suction line

Frost on a suction line  may indicate a flooded evaporator . A flooding evaporator is being fed more refrigerant than it can boil off and this may slug the compressor. Liquid leaving the evaporator may be indicated by frost on the suction line or compressor.
Read more

Omicron BA.2.75

In a recent study, researchers from Karolinska Institutet in Sweden, and others, have characterised the new omicron variant BA.2.75, comparing its ability to evade antibodies against current and previous variants. The study, published in the journal  The Lancet Infectious Diseases , suggests that BA.2.75 is not more resistant to antibodies than the currently dominating BA.5, which is positive news.
Read more